Search

everythinglearnresearchcommunity

for

Search:↓

Accurate diagnosis and personalized treatment are crucial for managing women's hair loss.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

Low vitamin D levels may affect ovulation and progesterone in infertile women.

Hormonal therapy like cyproterone acetate and spironolactone may help female hair loss, but more research is needed, especially for pre-menopausal women.

Found different long non-coding RNAs in balding Chinese men, which may help create new treatments.

Baldness may lower the risk of testicular cancer.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Testosterone with finasteride improved muscle and bone health in men with spinal cord injury.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

A new compound with strong antiandrogenic effects was found, potentially useful for treating conditions like acne and prostate cancer.

A new compound was made that might help treat diseases related to male hormones.

Antiandrogens affect androgen-dependent body functions and are used for various medical conditions, with some risks like fetus feminization, but new forms like 17α-propylmesterolone show promise for acne without systemic effects.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

The conclusion is that androgenetic alopecia and senescent alopecia have unique gene changes, suggesting different causes and potential treatments for these hair loss types.

Case-only trees and random forests improve predictions of treatment effects in clinical trials.

Male pattern baldness is mostly inherited, involves many genes, and is linked to other traits like early puberty and strong bones.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Researchers developed reliable models to predict how well certain compounds bind to androgen receptors, emphasizing the importance of atomic electronegativity.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

AR polyglycine repeat doesn't cause baldness.

Reduced AR gene methylation may cause early pubic hair growth in girls.

Endocrine therapies for cancer significantly increase the risk of hair loss.

AKR1D1 controls glucocorticoid levels and receptor activity in liver cells.

Finasteride helps regrow hair and shrink prostate by reducing DHT, with some sexual side effects.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.